StonvexLoading…
StonvexStonvexStonvexCore line items from RBBN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $844.56M | $833.88M | $826.34M | $819.76M |
Operating Income | $-3.32M | $16.87M | $-24.29M | $-48.32M |
Net Income | $39.64M | $-54.23M | $-66.21M | $-98.08M |
EPS (Diluted) | $0.22 | $-0.31 | $-0.39 | $-0.63 |
Total Assets | $1.21B | $1.16B | $1.14B | $1.26B |
Total Liabilities | $763.26M | $757.93M | $691.39M | $737.14M |
Cash & Equivalents | $96.41M | $87.77M | $26.49M | $67.26M |
Free Cash Flow OCF − CapEx | $26.06M | $27.83M | $7.71M | $-36.62M |
Shares Outstanding | 175.78M | 175.60M | 172.08M | 168.32M |